From Binding to Catalysis: Emergence of a Rudimentary Enzyme Conferring Intrinsic Antibiotic Resistance
Molecular Biology and Evolution · 2025
DOI: 10.1093/molbev/msaf215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology and Evolution, 2025. Verfasst von Claudèle Lemay-St-Denis und 8 weiteren Autor:innen. Beteiligte Einrichtung: PROTEO, The Québec Network for Research on Protein, Function, Engineering and Applications, Québec, Canada. Hauptthemen laut MEDLINE: Tetrahydrofolate Dehydrogenase, Drug Resistance, Microbial, Drug Resistance, Bacterial. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NSERC, Israel Science Foundation, the Minerva Foundation.
Abstract (Originalsprache)
How does enzymatic activity emerge? To shed light on this fundamental question, we study type B dihydrofolate reductases (DfrB), which were discovered for their role in antibiotic resistance. These rudimentary enzymes are evolutionarily distinct from the ubiquitous, monomeric FolA dihydrofolate reductases targeted by the antibiotic trimethoprim. DfrB is unique: it homotetramerizes to form a highly symmetrical central tunnel that accommodates its substrates in close proximity and the right orientation, thus promoting the metabolically essential production of tetrahydrofolate. It is the only known enzyme built from the ancient Src Homology 3 fold, typically a binding module. Strikingly, by studying the evolution of this enzyme family, we observe that no active-site residues are conserved across catalytically active homologs. Integrating experimental and computational analyses, we identify an intricate relationship between homotetramerization and catalytic activity, where formation of a tunnel featuring positive electrostatic potential proves to be a powerful predictor of activity. We demonstrate that the DfrB enzymes have not evolved in response to the synthetic antibiotic to which they confer strong resistance, and propose that DfrB domains evolved the capacity for rudimentary catalysis from a binding capacity. That (rudimentary) catalysis can emerge from the homotetramerization of a binding domain, and that it has been recently recruited by pathogenic bacteria, manifests the opportunistic nature of evolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PROTEO, The Québec Network for Research on Protein, Function, Engineering and Applications, Québec, Canada.
- CGCC, Center in Green Chemistry and Catalysis, Montréal, Canada.
- Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Canada.
- Department of Computer Science, University of Haifa, Haifa, Israel.
- bitBiome, Tokyo, Japan.
- Michael Smith Laboratories, University of British Columbia, Vancouver, Canada.
ORCID-Profile: Claudèle Lemay-St-Denis, Rachel Kolodny
Förderung
- NSERC
- Israel Science Foundation
- the Minerva Foundation
- APRENTICE
Zitieren
APA
Lemay-St-Denis, C., Cellier-Goetghebeur, S., St-Aubin, M., Ide, K., Copp, J. N., Tsuda, S., Ben-Tal, N., Kolodny, R., & Pelletier, J. N. (2025). From Binding to Catalysis: Emergence of a Rudimentary Enzyme Conferring Intrinsic Antibiotic Resistance. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/msaf215
Vancouver
Lemay-St-Denis C, Cellier-Goetghebeur S, St-Aubin M, Ide K, Copp JN, Tsuda S, et al. From Binding to Catalysis: Emergence of a Rudimentary Enzyme Conferring Intrinsic Antibiotic Resistance. Molecular Biology and Evolution. 2025. doi:10.1093/molbev/msaf215
BibTeX
@article{LemayStDenis2025,
author = {Lemay-St-Denis, Claudèle and Cellier-Goetghebeur, Stella and St-Aubin, Maxime and Ide, Keigo and Copp, Janine N and Tsuda, Soichiro and Ben-Tal, Nir and Kolodny, Rachel and Pelletier, Joelle N},
title = {From Binding to Catalysis: Emergence of a Rudimentary Enzyme Conferring Intrinsic Antibiotic Resistance},
journal = {Molecular Biology and Evolution},
year = {2025},
doi = {10.1093/molbev/msaf215}
}
EUVIMED